Sitagliptin BEKER® is a DPP-4 inhibitor (dipeptidylpeptidase 4 inhibitor) .It is indicated for the treatment of non-insulin-dependent diabetes as an adjunct to diet and exercise, either as monotherapy or in combination with other therapies. antidiabetic drugs.
DCI | SITAGLIPTINE |
---|---|
Dosage | 50 mg |
Trade name | SITAGLIPTINE BEKER ® |
Name of the originator | Januvia |
Presentation | 30 tablets |
Specialty | Métabolisme – ADO |